MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    COVID-19 impact on Anxiety, Depression, Stress, and Cortisol in Persons with Parkinson’s Disease

    B. Lobb, A. Hiller (Portland, USA)

    Objective: To assess psychological stress, through subjective and objective measures, in Parkinson’s disease (PD) prior to and during the worldwide pandemic. Background: We have had…
  • 2022 International Congress

    TRPV4 Mutation related Parkinson’s Disease with Scapuloperoneal spinal muscular atrophy

    A. Deenadayalu, P. A, V. Paramanandam (Limerick, Ireland)

    Objective: Scapuloperoneal spinal muscular atrophy (SPSMA) is a rare autosomal dominant disease caused by transient receptor potential cation channel (TRPV4) gene, involving scapular and peroneal…
  • 2022 International Congress

    Exosomes from human dental pulp stem cells as a cell-free drug delivery vehicle in vitro and in vivo chronic PD rat model through the intranasal route targeting efficacy & bio-distribution.

    I. Datta, A. Kaushal, K. Mondal (Bangalore, India)

    Objective: To evaluate the drug encasement in human dental pulp stem cell derived exosomes and its delivery in vitro in single cell level using fluorescence…
  • 2022 International Congress

    The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker

    S. Bhattacharjee, E. Vichayanrat, L. Watson, V. Iodice (London, United Kingdom)

    Objective: To analyze the sensitivity and specificity of the clonidine growth hormone (CGH) to distinguish probable multiple system atrophy (MSA) from pure autonomic failure (PAF),…
  • 2022 International Congress

    CORRELATION BETWEEN OLFACTORY DYSFUNCTION AND INTENSITY OF TREMOR

    D D. Pokhabov, V. Abramov, M. Sadovsky, D V. Pokhabov (Krasnoyarsk, Russian Federation)

    Objective: Our aim was to obtain tremor data of PD and ET patients and the results of their olfactory function, which can help verify our…
  • 2022 International Congress

    Discrepancies in postural stability outcomes measured by computerized dynamic posturography and functional balance assessments in Parkinson’s Disease

    E. Doctor, R. Bliss, J. Kanaley (Columbia, USA)

    Objective: To determine ideal assessment for detecting exercise-induced differences in postural stability of individuals with early-stage Parkinson’s Disease (PD). Background: Postural instability (PI) is a…
  • 2022 International Congress

    Cycling Deep Brain Stimulation for Parkinson’s Disease

    C. França, A. Bertholo, A. Pelicheck, I. Paraguay, J. Reis, D. Barros, J. Yamamoto, A. Coelho, R. Otani, M. Reuter, R. Carra, T. Guimarães, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)

    Objective: To compare gait disorders in patients with Parkinson's disease (PD) and Deep Brain Stimulation (DBS) using continuous vs cycling (40sec on, 2sec off) stimulation.…
  • 2022 International Congress

    Study of retinal and optic nerve ganglion cell layer in Parkinson’s disease and asymptomatic carriers of the LRRK2-G2019S mutation

    A. Cerveró, A. Sánchez-Rodríguez, M. Rivera-Sánchez, I. Martínez-Rodríguez, M. Sierra, I. González-Aramburu, A. Gutiérrez-González, J. Andrés-Pacheco, A. Casado, J. Infante (Santander, Spain)

    Objective: To study whether retinal nerve alterations can be a useful biomarker in presymptomatic stages of Parkinson's disease (PD) associated with the G2019S mutation of…
  • 2022 International Congress

    Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature

    L. Hickman, D. Fraser, J. Galea, J. Cook (Birmingham, United Kingdom)

    Objective: This study assessed kinematic profiles of individuals with Parkinson’s on and off dopaminergic medication to investigate whether the effect of dopaminergic modulation on speed…
  • 2022 International Congress

    Polymorphisms in Prosaposin gene are associated with familial and early-onset Parkinson’s disease: A case-control association study and meta-analysis

    YT. Chu, MC. Kuo, YA. Su, RM. Wu (Taipei, Taiwan)

    Objective: To investigate the role of the PSAP gene in PD patients in Taiwan, including familial PD and early-onset Parkinson’s disease. Background: Mutations in the…
  • « Previous Page
  • 1
  • …
  • 235
  • 236
  • 237
  • 238
  • 239
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley